{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:23:25Z","timestamp":1792023805718,"version":"4.4.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2495,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>\n                                 <jats:bold>Hepatitis C virus (HCV) is a major human pathogen that causes serious illness, including acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Using a mass spectrometry\u2013based proteomics approach, we have identified 175 proteins from a cell culture supernatant fraction containing the HCV genotype 2a (JFH1) virus, among which fatty acid synthase (FASN), the multifunctional enzyme catalyzing the<\/jats:bold>\n                                 <jats:bold>\n                                    de novo\n                                 <\/jats:bold>\n                                 <jats:bold>synthesis of fatty acids, was confirmed to be highly enriched. Subsequent studies showed that FASN expression increased in the human hepatoma cell line, Huh7, or its derivative, upon HCV infection. Blocking FASN activity by C75, a pharmacological FASN inhibitor, led to decreased HCV production. Reduction of FASN by RNA interference suppressed viral replication in both replicon and infection systems. Remarkably, FASN appeared to be selectively required for the expression of claudin-1, a tight junction protein that was recently identified as an entry coreceptor for HCV, but not for the expression of another HCV coreceptor, CD81. The decrease in Claudin-1 expression resulting from FASN inhibition was accompanied by a decrease in transepithelial electric resistance of Huh7 cells, implying a reduction in the relative tightness of the cell monolayer. Consequently, the entry of human immunodeficiency virus\u2013HCV pseudotypes was significantly inhibited in C75-treated Huh7 cells.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion:\n                                 <\/jats:bold>\n                                 <jats:bold>As far as we know, this is the first line of evidence that demonstrates that HCV infection directly induces FASN expression, and thus suggests a possible mechanism by which HCV infection alters the cellular lipid profile and causes diseases such as steatosis. (Hepatology 2008.)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.22508","type":"journal-article","created":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T13:06:31Z","timestamp":1215608791000},"page":"1396-1403","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":178,"title":["Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production"],"prefix":"10.1097","volume":"48","author":[{"given":"Wei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L.","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Conrads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20241201","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses.","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv Virus Res"},{"key":"R2-8-20241201","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nature04077","article-title":"Unravelling hepatitis C virus replication from genome to function.","volume":"436","author":"Lindenbach","year":"2005","journal-title":"Nature"},{"key":"R3-8-20241201","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hep.20032","article-title":"Structural biology of hepatitis C virus.","volume":"39","author":"Penin","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R4-8-20241201","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.arcmed.2006.09.001","article-title":"Hepatitis C and steatosis.","volume":"38","author":"Bjornsson","year":"2007","journal-title":"Arch Med Res"},{"key":"R5-8-20241201","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/MMBR.00042-06","article-title":"Viral proteomics.","volume":"71","author":"Maxwell","year":"2007","journal-title":"Microbiol Mol Biol Rev"},{"key":"R6-8-20241201","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1128\/JVI.78.3.1513-1524.2004","article-title":"Virushost cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis.","volume":"78","author":"Scholle","year":"2004","journal-title":"J Virol"},{"key":"R7-8-20241201","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1074\/jbc.M709824200","article-title":"Correlation of the tight junctionlike distribution of claudin1 to the cellular tropism of HCV.","volume":"283","author":"Yang","year":"2008","journal-title":"J Biol Chem"},{"key":"R8-8-20241201","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/bbrc.1998.8288","article-title":"Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids.","volume":"244","author":"Jiang","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R9-8-20241201","doi-asserted-by":"crossref","first-page":"13783","DOI":"10.1128\/JVI.01091-07","article-title":"Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture.","volume":"81","author":"Chang","year":"2007","journal-title":"J Virol"},{"key":"R10-8-20241201","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R11-8-20241201","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1517\/13543784.16.11.1817","article-title":"Fatty acid synthase inhibitors: new directions for oncology.","volume":"16","author":"Kridel","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"R12-8-20241201","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1073\/pnas.0700760104","article-title":"Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very lowdensity lipoproteins.","volume":"104","author":"Huang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-8-20241201","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1073\/pnas.0409834102","article-title":"Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids.","volume":"102","author":"Kapadia","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-8-20241201","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1073\/pnas.97.7.3450","article-title":"Synthesis and antitumor activity of an inhibitor of fatty acid synthase.","volume":"97","author":"Kuhajda","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-8-20241201","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1158\/1078-0432.CCR-07-1186","article-title":"Selective inhibition of fatty acid synthase for lung cancer treatment.","volume":"13","author":"Orita","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R16-8-20241201","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/viro.1997.8499","article-title":"Microvesicles are a source of contaminating cellular proteins found in purified HIV1 preparations.","volume":"230","author":"Bess","year":"1997","journal-title":"Virology"},{"key":"R17-8-20241201","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/viro.1997.8453","article-title":"Cell membrane vesicles are a major contaminant of gradientenriched human immunodeficiency virus type1 preparations.","volume":"230","author":"Gluschankof","year":"1997","journal-title":"Virology"},{"key":"R18-8-20241201","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1111\/j.1742-4658.2006.05379.x","article-title":"How does hepatitis C virus enter cells?","volume":"273","author":"Diedrich","year":"2006","journal-title":"FEBS J"},{"key":"R19-8-20241201","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3835(01)00464-5","article-title":"Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients.","volume":"167","author":"Wang","year":"2001","journal-title":"Cancer Lett"},{"key":"R20-8-20241201","first-page":"101","article-title":"Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer.","volume":"4","author":"Wang","year":"2004","journal-title":"J Exp Ther Oncol"},{"key":"R21-8-20241201","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/j.gastro.2003.01.001","article-title":"Hepatitis C: a metabolic liver disease.","volume":"126","author":"Weinman","year":"2004","journal-title":"Gastroenterology"},{"key":"R22-8-20241201","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection.","volume":"99","author":"Su","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-8-20241201","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.2001.1225","article-title":"Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins.","volume":"292","author":"Shi","year":"2002","journal-title":"Virology"},{"key":"R24-8-20241201","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb1631","article-title":"The lipid droplet is an important organelle for hepatitis C virus production.","volume":"9","author":"Miyanari","year":"2007","journal-title":"Nat Cell Biol"},{"key":"R25-8-20241201","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jhep.2006.10.019","article-title":"Upregulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype3a core has a stronger effect than genotype1b core.","volume":"46","author":"JackelCram","year":"2007","journal-title":"J Hepatol"},{"key":"R26-8-20241201","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1099\/vir.0.83491-0","article-title":"Activation of sterol regulatory elementbinding protein 1c and fatty acid synthase transcription by hepatitis C virus nonstructural protein 2.","volume":"89","author":"Oem","year":"2008","journal-title":"J Gen Virol"},{"key":"R27-8-20241201","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","article-title":"Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.","volume":"33","author":"RubbiaBrandt","year":"2000","journal-title":"J Hepatol"},{"key":"R28-8-20241201","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.virol.2004.03.034","article-title":"Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts.","volume":"324","author":"Aizaki","year":"2004","journal-title":"Virology"},{"key":"R29-8-20241201","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1128\/JVI.76.12.5974-5984.2002","article-title":"Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex.","volume":"76","author":"Egger","year":"2002","journal-title":"J Virol"},{"key":"R30-8-20241201","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin1 is a hepatitis C virus coreceptor required for a late step in entry.","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"R31-8-20241201","first-page":"331","article-title":"The molecular physiology of tight junction pores.","volume":"19","author":"Van Itallie","year":"2004","journal-title":"Physiology (Bethesda)"},{"key":"R32-8-20241201","doi-asserted-by":"crossref","first-page":"C1213","DOI":"10.1152\/ajpcell.00558.2003","article-title":"The tight junction: a multifunctional complex.","volume":"286","author":"Schneeberger","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"R33-8-20241201","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/JVI.01134-06","article-title":"Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I.","volume":"81","author":"Kapadia","year":"2007","journal-title":"J Virol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22508","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200811000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:41:06Z","timestamp":1733060466000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200811000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22508","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}